{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05336409",
            "orgStudyIdInfo": {
                "id": "CNTY-101-111-01 (ELiPSE-1)"
            },
            "organization": {
                "fullName": "Century Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies",
            "officialTitle": "The ELiPSE-1 Study: A Phase 1, Multicenter, Open-Label Study of CNTY-101 in Subjects With Relapsed or Refractory CD19-Positive B-Cell Malignancies",
            "acronym": "ELiPSE-1",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "a-study-of-cnty-in-participants-with-positive-b-cell-malignancies"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-01-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-04-08",
            "studyFirstSubmitQcDate": "2022-04-19",
            "studyFirstPostDateStruct": {
                "date": "2022-04-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-30",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Century Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "ELiPSE-1 is a Phase 1, multi-center, dose-finding study to evaluate the safety, pharmacokinetics, and preliminary efficacy of CNTY-101 in participants with relapsed or refractory cluster of differentiation (CD)19-positive B-cell malignancies."
        },
        "conditionsModule": {
            "conditions": [
                "R/R CD19-Positive B-Cell Malignancies",
                "Indolent Non-Hodgkin Lymphoma",
                "Aggressive Non-Hodgkin Lymphoma"
            ],
            "keywords": [
                "Lymphoma, Non-Hodgkin",
                "Lymphoma, Large B-Cell, Diffuse",
                "Lymphoma, Follicular",
                "Lymphoma, B-Cell, Marginal Zone",
                "Cellular therapy",
                "Cell therapy",
                "CNTY-101",
                "Century Therapeutics",
                "Induced pluripotent stem cells",
                "CAR-NK",
                "NK cell"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 75,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dose Escalation: Schedule A",
                    "type": "EXPERIMENTAL",
                    "description": "Lymphodepleting chemotherapy (LDC) will be followed by single dose administration of CNTY-101, alone or with supplemental human recombinant interleukin 2 (IL-2).",
                    "interventionNames": [
                        "Biological: CNTY-101",
                        "Biological: IL-2",
                        "Drug: Lymphodepleting Chemotherapy"
                    ]
                },
                {
                    "label": "Dose Escalation: Schedule B",
                    "type": "EXPERIMENTAL",
                    "description": "LDC will be followed by administration of CNTY-101, 3 times over 3 weeks, alone or with supplemental IL-2.",
                    "interventionNames": [
                        "Biological: CNTY-101",
                        "Biological: IL-2",
                        "Drug: Lymphodepleting Chemotherapy"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "CNTY-101",
                    "description": "CNTY-101 cells for intravenous (IV) infusion",
                    "armGroupLabels": [
                        "Dose Escalation: Schedule A",
                        "Dose Escalation: Schedule B"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "IL-2",
                    "description": "IL-2 subcutaneous (SQ) injection",
                    "armGroupLabels": [
                        "Dose Escalation: Schedule A",
                        "Dose Escalation: Schedule B"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Lymphodepleting Chemotherapy",
                    "description": "LDC as prespecified in the protocol.",
                    "armGroupLabels": [
                        "Dose Escalation: Schedule A",
                        "Dose Escalation: Schedule B"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Maximum Tolerated Dose (MTD) as Determined by the Percentage of Participants With Dose Limiting Toxicities (DLTs) and DLTs Based on Severity",
                    "timeFrame": "Up to 28 days"
                },
                {
                    "measure": "Recommended Phase 2 Regimen (RP2R) as Recommended by the Safety Review Committee (SRC)",
                    "timeFrame": "Up to 28 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Complete Response Rate (CRR) Based on Percentage of Participants Achieving Complete Response (CR)",
                    "description": "CRR will be determined using Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification.",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Objective Response Rate (ORR) Based on Percentage of Participants Achieving CR or Partial Response (PR)",
                    "description": "ORR will be determined using Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification.",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Duration of Response (DOR)",
                    "description": "DOR is defined as time from first response (CR or PR) to the first documentation of progressive disease (PD) or death.",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Time to Treatment Response (TTR)",
                    "description": "TTR is defined as time from first CNTY-101 infusion to the first documentation of response (CR or PR).",
                    "timeFrame": "Day 1 up to 2 years"
                },
                {
                    "measure": "Progression-Free Survival (PFS)",
                    "description": "PFS is defined as time from first CNTY-101 infusion to the first documentation of PD, or death from any cause, whichever occurs first",
                    "timeFrame": "Day 1 up to 2 years"
                },
                {
                    "measure": "Overall Survival (OS)",
                    "description": "OS is defined as time from CNTY-101 infusion to death.",
                    "timeFrame": "Day 1 up to 2 years"
                },
                {
                    "measure": "Cmax: Maximum Observed Plasma Concentration for CNTY-101",
                    "timeFrame": "Day 1 up to 2 years"
                },
                {
                    "measure": "Tmax: Time to Reach the Maximum Plasma Concentration for CNTY-101",
                    "timeFrame": "Day 1 up to 2 years"
                },
                {
                    "measure": "t1/2: Terminal Disposition Phase Half-life for CNTY-101",
                    "timeFrame": "Day 1 up to 2 years"
                },
                {
                    "measure": "AUC: Area under the Concentration-time Curve for CNTY-101",
                    "timeFrame": "Day 1 up to 2 years"
                },
                {
                    "measure": "Percentage of Participants With at Least one Treatment Emergent Adverse Event (TEAE)",
                    "timeFrame": "Day 1 up to 2 years"
                },
                {
                    "measure": "Percentage of Participants With Clinically Significant Laboratory Abnormalities",
                    "timeFrame": "Day 1 up to 2 years"
                },
                {
                    "measure": "Time to Treatment Initiation",
                    "description": "Time to treatment initiation is defined as the time from enrollment in the study to first CNTY-101 infusion.",
                    "timeFrame": "Enrollment to first CNTY-101 infusion (up to approximately 2 weeks)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Diagnosis of CD19-positive relapsed or refractory (R/R) B-cell Non-Hodgkin's Lymphoma (NHL).\n2. Must have met the following criteria for prior treatment:\n\n   1. Participants with aggressive NHL must have received at least 2 lines of systemic therapy (if not intended for transplant, have already undergone or be unwilling or unable to undergo chimeric antigen receptor \\[CAR\\] T-cell therapy to be eligible), or at least 3 lines of systemic therapy. Previous therapy must have included a CD20-targeted agent and an anthracycline or alkylator.\n   2. Participants with follicular lymphoma (FL) must have received at least 2 lines of systemic therapy and have high-risk disease. Previous therapy must have included a CD20-targeted agent and an alkylator.\n   3. Participants with marginal zone lymphoma (MZL) must have received at least 2 prior systemic therapies.\n3. Measurable disease on screening evaluations.\n4. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.\n5. Adequate organ function.\n6. Life expectancy of \u226512 weeks.\n\nExclusion Criteria:\n\n1. Any condition that confounds the ability to interpret data from the study.\n2. Central nervous system (CNS)-only involvement by malignancy. (Note: participants with secondary CNS involvement are allowed.)\n3. Prior allogeneic stem cell transplant.\n4. Presence of clinically significant CNS pathology.\n5. Other comorbid conditions defined in the protocol.\n6. Use of prohibited medications within the washout period defined in the protocol.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Nikolaus Trede",
                    "role": "CONTACT",
                    "phone": "888-506-7670",
                    "email": "ClinicalTeamCNTY@centurytx.com"
                }
            ],
            "locations": [
                {
                    "facility": "Banner MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Gilbert",
                    "state": "Arizona",
                    "zip": "85234",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dr. Matthew Ulrickson",
                            "role": "CONTACT",
                            "phone": "480-256-6444"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.35283,
                        "lon": -111.78903
                    }
                },
                {
                    "facility": "University of Southern California - Norris Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90033",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dr Yaghmour",
                            "role": "CONTACT",
                            "phone": "323-865-3170"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of California San Diego, Moores Cancer Center",
                    "status": "RECRUITING",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92093",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Benjamin Heyman",
                            "role": "CONTACT",
                            "phone": "858-822-6100",
                            "email": "bheyman@health.ucsd.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "Medstar Georgetown University Hospital",
                    "status": "RECRUITING",
                    "city": "Washington",
                    "state": "District of Columbia",
                    "zip": "20007",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dr. Renteria",
                            "role": "CONTACT",
                            "phone": "202-444-0939",
                            "email": "Anne.Renteria@medstar.net"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.89511,
                        "lon": -77.03637
                    }
                },
                {
                    "facility": "University of Kentucky - Markey Cancer Center",
                    "status": "RECRUITING",
                    "city": "Lexington",
                    "state": "Kentucky",
                    "zip": "40536",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dr. Chaitanya Iragavarapu",
                            "role": "CONTACT",
                            "phone": "859-257-4488",
                            "email": "c.iragavarapu@uky.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.98869,
                        "lon": -84.47772
                    }
                },
                {
                    "facility": "Henry Ford Hospital",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dr Mattour",
                            "role": "CONTACT",
                            "phone": "313-916-1266"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "Levine Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Charlotte",
                    "state": "North Carolina",
                    "zip": "28204",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dr Moyo",
                            "role": "CONTACT",
                            "phone": "980-442-2301"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.22709,
                        "lon": -80.84313
                    }
                },
                {
                    "facility": "University of Cincinnati Medical Center",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dr Latif",
                            "role": "CONTACT",
                            "phone": "513-584-7824"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Oncology Hematology Care, Inc-Kenwood",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45236",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dr. James Essell",
                            "role": "CONTACT",
                            "phone": "513-751-2273",
                            "email": "james.essell@usoncology.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Vanderbilt University Medical Center",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37232",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dr. Olalekan Oluwole",
                            "role": "CONTACT",
                            "phone": "615-875-0060",
                            "email": "olalekan.oluwole@vumc.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "UT Southwestern",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75390",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Praveen Ramakrishnan, MD",
                            "role": "CONTACT",
                            "phone": "214-645-4673"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Houston Methodist Research Institute",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dr. Pingali",
                            "role": "CONTACT",
                            "phone": "713-441-9948",
                            "email": "spingali@houstonmethodist.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Virginia Oncology Associates",
                    "status": "RECRUITING",
                    "city": "Norfolk",
                    "state": "Virginia",
                    "zip": "23502",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dr. Scott Cross",
                            "role": "CONTACT",
                            "phone": "757-466-8683",
                            "email": "scott.cross@usoncology.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.84681,
                        "lon": -76.28522
                    }
                },
                {
                    "facility": "Swedish Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dr Patel",
                            "role": "CONTACT",
                            "phone": "206-386-2301"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008228",
                    "term": "Lymphoma, Non-Hodgkin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11222",
                    "name": "Lymphoma, Non-Hodgkin",
                    "asFound": "Non-Hodgkin Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18828",
                    "name": "Lymphoma, B-Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M18831",
                    "name": "Lymphoma, Large B-Cell, Diffuse",
                    "relevance": "LOW"
                },
                {
                    "id": "M11221",
                    "name": "Lymphoma, Follicular",
                    "relevance": "LOW"
                },
                {
                    "id": "M20554",
                    "name": "Lymphoma, B-Cell, Marginal Zone",
                    "relevance": "LOW"
                },
                {
                    "id": "M3724",
                    "name": "Aggression",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T640",
                    "name": "B-cell Lymphoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T2361",
                    "name": "Follicular Lymphoma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M10411",
                    "name": "Interleukin-2",
                    "relevance": "LOW"
                },
                {
                    "id": "M6263",
                    "name": "Coal Tar",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Derm",
                    "name": "Dermatologic Agents"
                }
            ]
        }
    },
    "hasResults": false
}